Guardant Health, Inc. - Common Stock (NQ:GH)

185.31 +2.72 (+1.49%)

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Guardant Health, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

23 24 Next >

Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday ↗

January 21, 2025

Via Benzinga

Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients

January 21, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

January 16, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

January 13, 2025

From Guardant Health, Inc.

Via Business Wire

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio? ↗

January 12, 2025

These mid-cap stocks had impressive gains last week, including Inari Medical, Unifirst Corporation, and Walgreens. Are they in your portfolio?

Via Benzinga

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

January 07, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 02, 2025

From Guardant Health, Inc.

Via Business Wire

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

December 20, 2024

From Guardant Health, Inc.

Via Business Wire

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics

December 19, 2024

From COTA Inc.

Via Business Wire

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer

December 18, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium

December 09, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health Stock Sees RS Rating Jump To 83 ↗

November 20, 2024

On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83.

Via Investor's Business Daily

Deciphering Disruption: Inside Cathie Wood's Latest Plays

November 16, 2024

Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.

Via MarketBeat

Topics Artificial Intelligence ETFs

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 13, 2024

From Guardant Health, Inc.

Via Business Wire

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

November 12, 2024

The rock star money manager is starting to roll with the rallying market.

Via The Motley Fool

Smaller Cap Biotechs Are In Season: How Are We Doing? ↗

November 07, 2024

SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range.

Via Talk Markets

Why Guardant Health Stock Blasted 13% Higher on Thursday ↗

November 07, 2024

Via The Motley Fool

HubSpot Posts Better-Than-Expected Results, Joins Under Armour, Lyft, Wolverine World Wide, Zillow And Other Big Stocks Moving Higher On Thursday ↗

November 07, 2024

Via Benzinga

Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop ↗

November 07, 2024

The company also hiked its outlook for the year and guided to 20% growth in clinical volumes next year.

Via Investor's Business Daily

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

November 06, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming Investor Conferences

November 01, 2024

From Guardant Health, Inc.

Via Business Wire

Why Guardant Health Stock Was the Picture of Health Today ↗

October 30, 2024

There's nothing like free publicity to help goose the sales of a relatively new product.

Via The Motley Fool

Guardant Health Named to TIME’s List of the Best Inventions of 2024

October 30, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024

October 28, 2024

From Guardant Health, Inc.

Via Business Wire

Roberto A. Mignone Joins Guardant Health Board of Directors

October 24, 2024

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024

October 15, 2024

From Guardant Health, Inc.

Via Business Wire

FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test ↗

October 04, 2024

Exact Sciences' Cologuard Plus test, now FDA-approved, offers a non-invasive screening option for adults 45+ at average risk for colorectal cancer. The test outperformed fecal immunochemical tests in...

Via Benzinga

GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long

September 18, 2024

From Guardant Health, Inc.

Via Business Wire

Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

September 17, 2024

Via Benzinga

iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 16, 2024

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.